Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1996. Start Trial.
Date Value
March 31, 2026 62.14%
December 31, 2025 59.95%
September 30, 2025 62.07%
June 30, 2025 62.90%
March 31, 2025 62.90%
December 31, 2024 45.68%
September 30, 2024 61.78%
June 30, 2024 60.28%
March 31, 2024 60.84%
December 31, 2023 47.86%
September 30, 2023 49.03%
June 30, 2023 48.58%
March 31, 2023 50.41%
December 31, 2022 50.79%
September 30, 2022 51.43%
June 30, 2022 45.67%
March 31, 2022 67.30%
December 31, 2021 65.60%
September 30, 2021 66.25%
June 30, 2021 63.23%
March 31, 2021 65.84%
December 31, 2020 63.35%
September 30, 2020 64.34%
June 30, 2020 63.66%
March 31, 2020 68.85%
Date Value
December 31, 2019 67.44%
September 30, 2019 68.24%
June 30, 2019 67.21%
March 31, 2019 65.46%
December 31, 2018 66.48%
September 30, 2018 66.84%
June 30, 2018 67.17%
March 31, 2018 67.66%
December 31, 2017 66.68%
September 30, 2017 64.16%
June 30, 2017 65.99%
March 31, 2017 67.34%
December 31, 2016 67.86%
September 30, 2016 65.70%
June 30, 2016 66.69%
March 31, 2016 66.73%
December 31, 2015 60.83%
September 30, 2015 65.09%
June 30, 2015 64.77%
March 31, 2015 65.41%
December 31, 2014 67.47%
September 30, 2014 66.21%
June 30, 2014 65.42%
March 31, 2014 65.37%
December 31, 2013 62.86%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Danaher Corp. 57.64%
Accuray, Inc. 34.76%
ResMed, Inc. 58.12%
Rockwell Medical, Inc. 18.24%
Microbot Medical, Inc. -273.0%

Gross Profit Margin (Quarterly) Related Metrics